Today, we have shortlisted 12 U.S healthcare stocks that are expected to report strong gross profit, operating profit and net profit margins for fiscal year 2014. Moreover, during past one month these stocks have registered price gains with daily average trading volumes in excess of 100,000.
| Company Name |
Ticker |
Exchange |
Market Cap |
Last Price |
Average Volume |
Price Change (1-Month) |
Gross Margin 2014(E) |
Operating Margin 2014(E) |
Net Profit Margin 2014(E) |
|
Anika Therapeutics Inc |
ANIK |
NASDAQ |
593.2 |
40.90 |
240,730 |
9.9% |
71.7% |
58.0% |
35.9% |
|
Lannett Co Inc |
LCI |
NYSE |
1,823.3 |
50.99 |
862,923 |
23.1% |
75.0% |
53.8% |
33.9% |
|
ANI Pharmaceuticals Inc |
ANIP |
NASDAQ |
507.2 |
44.79 |
261,116 |
68.3% |
79.6% |
33.9% |
29.4% |
|
Insys Therapeutics Inc |
INSY |
NASDAQ |
1,289.6 |
37.37 |
511,294 |
-6.0% |
88.8% |
31.7% |
27.7% |
|
Bio-Techne Corp |
TECH |
NASDAQ |
3,374.3 |
91.17 |
228,335 |
-0.4% |
70.7% |
40.8% |
26.6% |
|
Akorn Inc |
AKRX |
NASDAQ |
3,944.6 |
37.88 |
1,556,515 |
5.2% |
56.0% |
36.3% |
20.7% |
|
Globus Medical Inc |
GMED |
NYSE |
2,610.9 |
22.06 |
752,015 |
13.1% |
77.2% |
28.9% |
19.2% |
|
Align Technology Inc |
ALGN |
NASDAQ |
4,225.7 |
52.63 |
925,966 |
11.9% |
75.6% |
25.5% |
19.2% |
|
Meridian Bioscience Inc |
VIVO |
NASDAQ |
744.5 |
17.91 |
206,152 |
2.5% |
62.6% |
28.4% |
18.9% |
|
Myriad Genetics Inc |
MYGN |
NASDAQ |
2,538.4 |
34.78 |
779,317 |
-7.2% |
81.3% |
26.9% |
17.1% |
|
Sucampo Pharmaceuticals Inc |
SCMP |
NASDAQ |
405.7 |
9.16 |
104,353 |
34.3% |
85.5% |
25.6% |
13.8% |
|
Prestige Brands Holdings Inc |
PBH |
NYSE |
1,947.1 |
37.32 |
270,129 |
18.8% |
58.4% |
32.8% |
13.5% |
Source: Bloomberg
Company Description
Anika Therapeutics Inc (NASDAQ: ANIK)
Anika Therapeutics, Inc. develops, manufactures, and commercializes therapeutic products and devices. The company’s products, based on hyaluronic acid, promote the repair, protection, and healing of bone, cartilage, and soft tissue. Anika’s products include ORTHOVISC and HYVISC which treat osteoarthritis.
Lannett Co Inc (NYSE: LCI)
Lannett Company, Inc. manufactures and distributes pharmaceutical products under its own trade name and under generic names. The Company also distributes competitive pharmaceutical products manufactured by other companies. The principal products include antifungals, antacids, dermatological preparations, and analgesic sedatives.
ANI Pharmaceuticals Inc (NASDAQ: ANIP)
ANI Pharmaceuticals, Inc. is an integrated specialty pharmaceutical company. The Company develops, manufactures and markets branded and generic prescription pharmaceuticals. ANI manufactures oral solid dose products, as well as liquids and topicals.
Insys Therapeutics Inc (NASDAQ: INSY)
Insys Therapeutics, Inc. develops cancer support drugs. The company’s support care candidates include a fast-acting sublingual spray for cancer pain; and a dronabinol product used to treat chemotherapy-induced nausea and vomiting and to stimulate appetite in AIDS patients.
Bio-Techne Corp (NASDAQ: TECH)
Bio-Techne Corp develops, manufactures and sells biotechnology products and clinical diagnostic controls. The company specializes in proteins, cytokines, growth factors, immunoassays and small molecules.
Akorn Inc (NASDAQ: AKRX)
Akorn, Inc. develops, manufactures, and markets ophthalmic and injectable pharmaceutical products. The company sells various diagnostic and therapeutic pharmaceutical products focused primarily on ophthalmology, anesthesia, antidotes, and rheumatology. Akorn also markets ophthalmic surgical instruments and other supplies, and provides contract manufacturing for third parties.
Globus Medical Inc (NYSE: GMED)
Globus Medical, Inc. is a medical device company. The company is focused exclusively on the design, development and commercialization of products that promote healing in patients with spine disorders. Globus Medical’s products fall into innovative fusion or disruptive technologies.
Align Technology Inc (NASDAQ: ALGN)
Align Technology, Inc. designs, manufactures, and markets the Invisalign System, a method for treating the misalignment of teeth. The company’s system corrects the misalignment using a series of clear, removable appliances that move teeth to a desired final position.
Meridian Bioscience Inc (NASDAQ: VIVO)
Meridian Bioscience, Inc. manufactures, markets, and distributes diagnostic test kits, purified reagents, and related products. The company also offers biopharmaceutical enabling technologies. Meridian specializes in gastrointestinal and upper respiratory infections, serology, parasitology, and fungal disease diagnosis, as well as rare reagents and specialty biologicals.
Myriad Genetics Inc (NASDAQ: MYGN)
Myriad Genetics, Inc. develops and markets molecular diagnostic products to provide physicians with information to help guide the care of their patients, to prevent disease, delay the onset of disease, or catch disease at an early stage.
Sucampo Pharmaceuticals Inc (NASDAQ: SCMP)
Sucampo Pharmaceuticals, Inc. researches and develops drugs based on protones, which are derived from functional fatty acids. The company produces a prescription drug for the treatment of chronic idiopathic constipation.
Prestige Brands Holdings Inc (NYSE: PBH)
Prestige Brands Holdings, Inc. distributes over-the-counter healthcare and household cleaning products to retail stores in the United States, Canada and other international markets. The company distributes oral, eye and skin care; cough, cold, allergy and sinus; and household cleansers, sponges, scrubbers and cleaning pads.
